Skip to content
PICO Portalanswers from OpenAlex

Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism

PaperCitations, authors & open-access status

Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism is a paper indexed in PICO Portal from OpenAlex.

How many citations does Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism have?

PICO Portalcitation count

Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism has 129 citations in the OpenAlex counts PICO Portal stores.

When was Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism published?

PICO Portalyear

Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism has 2000 year in the PICO Portal index.

What is the open-access status of Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism?

PICO Portaloa status

Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism has closed oa status in the PICO Portal index.

What is the DOI of Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism?

PICO Portaldoi

The DOI for Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism is on the source record.

What is the PMID of Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism?

PICO Portalpmid

The PMID for Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism is on the source record.

What is the OpenAlex record for Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism?

PICO Portalopenalex

The OpenAlex for Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial